NCT06192550View on ClinicalTrials.gov

Functional Usability and Feasibility Testing of the Profound Matrix™ System

NACompletedINTERVENTIONAL
Enrollment

193

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

September 27, 2023

Study Completion Date

December 29, 2023

Conditions
WrinkleAcne Scars - Mixed Atrophic and Hypertrophic
Interventions
DEVICE

Profound Matrix™ System

Study subjects will be treated with the Profound Matrix System

Trial Locations (5)

10028

NY Derm, New York

10128

OptiSkin, New York

28207

Laser & Vein Specialists of the Carolinas, Charlotte

01752

Candela Institue for Excellence, Marlborough

Unknown

Syneron Medical, Yokneam Illit

Sponsors
All Listed Sponsors
lead

Candela Corporation

INDUSTRY

NCT06192550 - Functional Usability and Feasibility Testing of the Profound Matrix™ System | Biotech Hunter | Biotech Hunter